Grants and Contributions:
Title:
A Cancer Immunotherapy Harnessing Pre-Existing Antibodies in Humans
Agreement Number:
1028951
Agreement Value:
$25,000.00
Agreement Date:
Mar 26, 2025 - Sep 30, 2026
Description:
Advances exploratory research under the New Beginnings Initiative
Organization:
National Research Council Canada
Expected Results:
In the short term, anticipated outcomes will be strengthened collaborations across industry, academia, and government to support research excellence. In the medium term, anticipated outcomes will be the development of new and potentially disruptive technologies with collaborators.
Location:
Ottawa, Ontario, CA K1H 8L6
Reference Number:
172-2024-2025-Q4-1028951
Agreement Type:
Grant
Report Type:
Grants and Contributions
Recipient Business Number:
886822212
Recipient Type:
Not-for-profit organization or charity
Recipient's Legal Name:
Ottawa Hospital Research Institute
Federal Riding Name:
Ottawa South
Federal Riding Number:
35080
Program:
Collaborative Science, Technology and Innovation Program – Ideation Fund
Program Purpose:
The Ideation Fund is intended to encourage, test and validate transformative research ideas generated by teams of NRC scientific personnel and external collaborators with complementary capabilities, acting as a demonstration phase for a continually-evolving suite of research and development (R&D) deliverables at the NRC. The fund supports exploratory research through two mechanisms: the New Beginnings Initiative and the Small Teams Initiative.
NAICS Code:
541710